FindTrial
Sign In

Use of the new supraglottic device Ambu AuraGain in clinical settings

Use of the new supraglottic device Ambu AuraGain in clinical settings - Use of the AuraGain in clinical settings

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000020625
Enrollment
Unknown
Registered
2016-01-19
Start date
2016-01-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

the cases inserted the new supraglottic device Ambu AuraGain

Interventions

None listed

Sponsors

Showa University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: the cases inserted the AuraGain

Exclusion criteria

Exclusion criteria: the cases not inserted the AuraGain

Design outcomes

Primary

MeasureTime frame
the number of insertion—

Countries

Japan

Contacts

Public ContactHironobu Ueshima

Showa University Hospital Anesthesiology

ueshimhi@yahoo.co.jp03-3784-8575

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026